Skip to main content
SpringerLink
Log in

CD4+CD25+ Regulatory T Cells in Hematopoietic Stem Cell Transplantation

  • Chapter
CD4+CD25+ Regulatory T Cells: Origin, Function and Therapeutic Potential

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 293))

Abstract

Allogeneic hematopoietic stem cell transplantation (SCT) is a well-established treatment modality for malignant and nonmalignant hematologic diseases. High-dose radio-and/or chemotherapy eradicate the hematopoietic system of the patient and induce sufficient immunosuppression to enable donor stem cell engraftment. The replacement of the recipient’s immune system with that of the donor significantly contributes to the success of this treatment, since donor immune cells facilitate stem cell engraftment, provide protection from infections, and eliminate residual malignant or nonmalignant host hematopoiesis, thereby protecting from disease relapse in patients transplanted for leukemia or lymphoma (graft-versus-leukemia effect, GVL). Mediators of these beneficial effects are mature T cells within the stem cell graft. However, donor T cells can also attack host tissues and induce a life-threatening syndrome called graft-versus-host disease (GVHD). The challenge of allogeneic SCT is to find a balance between beneficial and harmful T cell effects, which at present is only insufficiently achieved by the use of immunosuppressive drugs. In the future, it might be possible to replace or support such medications by using the intrinsic regulatory capacity of the transplanted immune system, as represented by T cell subpopulations with suppressive activity, such as CD4+CD25+ regulatory T (Treg) cells. In various mouse model systems, these cells have been shown to suppress GVHD while preserving the GVL effect. As the characterization of their human counterparts is rapidly progressing, their application in allogeneic SCT might soon be explored in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Almeida AR, Legrand N et al (2002) Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 169:4850–60

    PubMed  Google Scholar 

  • Amrolia PJ, Muccioli-Casadei G et al (2003a) Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. Blood 102:2292–2299

    Article  PubMed  CAS  Google Scholar 

  • Amrolia PJ, Reid SD et al (2003b) Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity. Blood 101:1007–1014

    Article  PubMed  CAS  Google Scholar 

  • Anderson BE, McNiff J et al (2003) Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest 112:101–108

    Article  PubMed  CAS  Google Scholar 

  • Annacker O, Pimenta-Araujo R et al (2001) CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 166:3008–3018

    PubMed  CAS  Google Scholar 

  • Bachar-Lustig E, Reich-Zeliger S et al (2003) Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose. Blood 102:1943–1950

    Article  PubMed  CAS  Google Scholar 

  • Bader P, Kreyenberg H et al (2004) Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? J Clin Oncol 22:1696–1705

    Article  PubMed  Google Scholar 

  • Baecher-Allan C, Viglietta V et al (2004) Human CD4+CD25+ regulatory T cells. Semin Immunol 16:89–98

    Article  PubMed  CAS  Google Scholar 

  • Belkaid Y, Piccirillo CA et al (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420(6915):502–507

    Article  PubMed  CAS  Google Scholar 

  • Blazar BR, Taylor PA et al (1997) Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol 158:29–39

    PubMed  CAS  Google Scholar 

  • Cederbom L, Hall H et al (2000) CD4+CD25+ regulatory T cells down-regulate costimulatory molecules on antigen-presenting cells. Eur J Immunol 30:1538–1543

    Article  PubMed  CAS  Google Scholar 

  • Champlin RE, Passweg JR et al (2000) T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood 95:3996–4003

    PubMed  CAS  Google Scholar 

  • Chen BJ, Cui X et al (2002) Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process. Blood 99:3083–3088

    PubMed  CAS  Google Scholar 

  • Chen BJ, Cui X et al (2004) Transfer of allogeneic CD62L-memory T cells without graft-versus-host disease. Blood 103:1534–1541

    PubMed  CAS  Google Scholar 

  • Cobbold SP, Graca L et al (2003) Regulatory T cells in the induction and maintenance of peripheral transplantation tolerance. Transpl Int 16:66–75

    Article  PubMed  CAS  Google Scholar 

  • Cohen JL, Trenado A et al (2002) CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 196:401–406

    PubMed  CAS  Google Scholar 

  • Daniel C, Horvath S et al (1998) Abasis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR Immunity 8:543–552

    CAS  Google Scholar 

  • Dazzi F, Szydlo RM et al (2000) Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood 95:67–71

    PubMed  CAS  Google Scholar 

  • Dickinson AM, Wang XN et al (2002) In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med 8:410–414

    Article  PubMed  CAS  Google Scholar 

  • Dieckmann D, Plottner H et al (2001) Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 193:1303–1310

    Article  PubMed  CAS  Google Scholar 

  • Edinger M, Cao YA et al (2003a) Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101:640–648

    Article  PubMed  CAS  Google Scholar 

  • Edinger M, Hoffmann P et al (2003b) CD4(+)CD25(+) regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9:1144–1150

    Article  PubMed  CAS  Google Scholar 

  • Ermann J, Hoffmann P et al. (2005) Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood 105:2220–2226

    Article  PubMed  CAS  Google Scholar 

  • Ermann J, Szanya V et al (2001) CD4(+)CD25(+) T cells facilitate the induction of T cell anergy. J Immunol 167:4271–4275

    PubMed  CAS  Google Scholar 

  • Falkenburg JH, van de Corput L et al (2003) Minor histocompatibility antigens in human stem cell transplantation. Exp Hematol 31:743–751

    Article  PubMed  CAS  Google Scholar 

  • Ferrara JL (2000) Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematother Stem Cell Res 9:299–306

    Article  PubMed  CAS  Google Scholar 

  • Ferrara JL, Levy R et al (1999) Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transplant 5:347–356

    Article  PubMed  CAS  Google Scholar 

  • Fisson S, Darrasse-Jeze G et al (2003) Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med 198:737–746

    Article  PubMed  CAS  Google Scholar 

  • Gavin MA, Clarke SR et al (2002) Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat Immunol 3:33–41

    PubMed  CAS  Google Scholar 

  • Godfrey WR, Ge YG et al (2004) In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104:453–461

    Article  PubMed  CAS  Google Scholar 

  • Goulmy E (1997) Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 157:125–140

    PubMed  CAS  Google Scholar 

  • Graca L, Cobbold SP et al (2002) Identification of regulatory T cells in tolerated allografts. J Exp Med 195:1641–1646

    Article  PubMed  CAS  Google Scholar 

  • Gratwohl A, Brand R et al (2002) Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood 100:3877–3886

    PubMed  CAS  Google Scholar 

  • Green EA, Choi Y et al (2002) Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16:183–191

    Article  PubMed  CAS  Google Scholar 

  • Guglielmi C, Arcese W et al (2002) Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose. Blood 100:397–405

    Article  PubMed  CAS  Google Scholar 

  • Guinan EC, Boussiotis VA et al (1999) Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 340:1704–1714

    Article  PubMed  CAS  Google Scholar 

  • Hanash AM, Levy RB (2003) Donor CD4+CD25+ T cells facilitate hematopoietic engraftment independent of host resistance and allo-antigen recognition (abstract) Blood 102:38a

    Google Scholar 

  • Heemskerk MH, Hoogeboom M et al (2003) Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region. Blood 102:3530–3540

    Article  PubMed  CAS  Google Scholar 

  • Hertenstein B, Hampl W et al (1995) In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT. Bone Marrow Transplant 15:387–393

    PubMed  CAS  Google Scholar 

  • Heslop HE, Brenner MK et al (1994) Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Hum Gene Ther 5:381–397

    PubMed  CAS  Google Scholar 

  • Ho VT, Soiffer RJ (2001) The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 98:3192–204

    PubMed  CAS  Google Scholar 

  • Hoffmann P, Eder R et al (2004) Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104:895–903

    Article  PubMed  CAS  Google Scholar 

  • Hoffmann P, Edinger M et al (2002b) CD4+CD25+ regulatory T cells act in secondary lymphoid organs to protect from lethal acute GVHD (abstract) Blood 100:143a

    Google Scholar 

  • Hoffmann P, Ermann J et al (2002a) Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196:389–399

    Article  PubMed  CAS  Google Scholar 

  • Huehn J, Siegmund K et al (2004) Developmental stage phenotype, and migration distinguish naive-and effector/memory-like CD4+ regulatory T cells. J Exp Med 199:303–313

    Article  PubMed  CAS  Google Scholar 

  • Iellem A, Mariani M et al (2001) Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 194:847–853

    Article  PubMed  CAS  Google Scholar 

  • Ildstad ST, Sachs DH (1984) Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307(5947):168–170

    Article  PubMed  CAS  Google Scholar 

  • Jiang S, Camara N et al (2003) Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood 102:2180–2186

    PubMed  CAS  Google Scholar 

  • Joffre O, Gorsse N et al (2004) Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. Blood 103:4216–4221

    Article  PubMed  CAS  Google Scholar 

  • Johnson BD, Becker EE et al (1999) Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. J Immunol 163:6479–6487

    PubMed  CAS  Google Scholar 

  • Johnson BD, Konkol MC et al (2002) CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biol Blood Marrow Transplant 8:525–535

    PubMed  Google Scholar 

  • Jones SC, Murphy GF et al (2003) Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD4(+)25(+) T cells to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant 9:243–256

    Article  PubMed  Google Scholar 

  • Jonuleit H, Schmitt E et al (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192:1213–1222

    Article  PubMed  CAS  Google Scholar 

  • Jonuleit H, Schmitt E et al (2001) Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285–1294

    Article  PubMed  CAS  Google Scholar 

  • Klein L, Khazaie K et al (2003) In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci U S A 100:8886–8891

    PubMed  CAS  Google Scholar 

  • Kolb HJ, Mittermuller J et al (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462–2465

    PubMed  CAS  Google Scholar 

  • Kubsch S, Graulich E et al (2003) Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2-and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1. Eur J Immunol 33:1988–1997

    Article  PubMed  CAS  Google Scholar 

  • Lechler RI, Garden OA et al (2003) The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 3:147–158

    Article  PubMed  CAS  Google Scholar 

  • Lehmann J, Huehn J et al (2002) Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25− regulatory T cells. Proc Natl Acad Sci U S A 99:13031–13036

    PubMed  CAS  Google Scholar 

  • Levings MK, Sangregorio R et al (2001) Human CD25(+)CD4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193:1295–1302

    Article  PubMed  CAS  Google Scholar 

  • Li B, New JY et al (2004) Delaying acute graft-versus-host disease in mouse bone marrow transplantation by treating donor cells with antibodies directed at L-selectin and alpha4-integrin prior to infusion. Scand J Immunol 59:464–468

    Article  PubMed  CAS  Google Scholar 

  • Li B, New JY et al (2001) Blocking L-selectin and alpha4-integrin changes donor cell homing pattern and ameliorates murine acute graft versus host disease. Eur J Immunol 31:617–624

    PubMed  CAS  Google Scholar 

  • Li XC, Strom TB et al (2001) T cell death and transplantation tolerance. Immunity 14:407–416

    PubMed  CAS  Google Scholar 

  • Malek TR, Yu A et al (2002) CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17:167–178

    Article  PubMed  CAS  Google Scholar 

  • Merad M, Hoffmann P et al (2004) Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med 10:510–517

    PubMed  CAS  Google Scholar 

  • Michalek J, Collins RH et al (2003) Clinical-scale selective depletion of alloreactive T cells using an anti-CD25 immunotoxin. Neoplasma 50:296–299

    PubMed  CAS  Google Scholar 

  • Misra N, Bayry J et al (2004) Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol 172:4676–4680

    PubMed  CAS  Google Scholar 

  • Miura Y, Thoburn CJ et al (2004) Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 104:2187–2193

    Article  PubMed  CAS  Google Scholar 

  • Molldrem JJ, Lee PP et al (2000) Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med 6:1018–1023

    Article  PubMed  CAS  Google Scholar 

  • Moore KW, de Waal Malefyt R et al (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765

    Article  PubMed  CAS  Google Scholar 

  • Mottet C, Uhlig HH et al (2003) Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170:3939–3943

    PubMed  CAS  Google Scholar 

  • Murai M, Yoneyama H et al (2003) Peyer’s patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol 4:154–160

    Article  PubMed  CAS  Google Scholar 

  • Obst R, Netuschil N et al (2000) The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules. J Exp Med 191:805–812

    Article  PubMed  CAS  Google Scholar 

  • Orsini E, Alyea EP et al (2000) Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma. Biol Blood Marrow Transplant 6:375–386

    Article  PubMed  CAS  Google Scholar 

  • Patterson J, Prentice HG et al (1986) Graft rejection following HLA matched Tlymphocyte depleted bone marrow transplantation. Br J Haematol 63:221–230

    PubMed  CAS  Google Scholar 

  • Piccirillo CA, Shevach EM (2004) Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 16:81–88

    Article  PubMed  CAS  Google Scholar 

  • Porter DL, Collins RH Jr et al (1999) Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions. Biol Blood Marrow Transplant 5:253–261

    Article  PubMed  CAS  Google Scholar 

  • Rauser G, Einsele H et al (2004) Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 103:3565–3572

    Article  PubMed  CAS  Google Scholar 

  • Read S, Malmstrom V et al (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192:295–302

    Article  PubMed  CAS  Google Scholar 

  • Riddell SR, Murata M et al (2002) Minor histocompatibility antigens—targets of graft versus leukemia responses. Int J Hematol 76Suppl 2:155–161

    PubMed  Google Scholar 

  • Rocha B, von Boehmer H (1991) Peripheral selection of the T cell repertoire. Science 251:1225–1228

    PubMed  CAS  Google Scholar 

  • Roncarolo MG, Bacchetta R et al (2001) Type 1 T regulatory cells. Immunol Rev 182:68–79

    Article  PubMed  CAS  Google Scholar 

  • Sakaguchi S (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455–458

    Article  PubMed  CAS  Google Scholar 

  • Sakaguchi S (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531–562

    Article  PubMed  CAS  Google Scholar 

  • Salaun J, Bandeira A et al (1990) Thymic epithelium tolerizes for histocompatibility antigens. Science 247:1471–1474

    PubMed  CAS  Google Scholar 

  • Salomon B, Lenschow DJ et al (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431–440

    Article  PubMed  CAS  Google Scholar 

  • Savage P, Gao L et al (2004) Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen. Blood 103:4613–4615

    Article  PubMed  CAS  Google Scholar 

  • Sebastiani S, Allavena P et al (2001) Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol 166:996–1002

    PubMed  CAS  Google Scholar 

  • Serrano J, Roman J et al (2000) Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse. Blood 95:2659–2665

    PubMed  CAS  Google Scholar 

  • Shlomchik WD, Couzens MS et al (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285:412–415

    Article  PubMed  CAS  Google Scholar 

  • Sprent J, Kishimoto H (2001) The thymus and central tolerance. Philos Trans R Soc Lond B Biol Sci 356:609–616

    PubMed  CAS  Google Scholar 

  • Sprent J, Schaefer M et al (1986) Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med 163:998–1011

    Article  PubMed  CAS  Google Scholar 

  • Sprent J, Webb SR (1995) Intrathymic and extrathymic clonal deletion of T cells. Curr Opin Immunol 7:196–205

    Article  PubMed  CAS  Google Scholar 

  • Steinbrink K, Wolfl M et al (1997) Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159:4772–4780

    PubMed  CAS  Google Scholar 

  • Suchin EJ, Langmuir PB et al (2001) Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 166:973–981

    PubMed  CAS  Google Scholar 

  • Suri-Payer E, Cantor H (2001) Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J Autoimmun 16:115–123

    Article  PubMed  CAS  Google Scholar 

  • Sykes M, Sachs DH (2001) Mixed chimerism. Philos Trans R Soc Lond B Biol Sci 356:707–726

    PubMed  CAS  Google Scholar 

  • Szanya V, Ermann J et al (2002) The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol 169:2461–2465

    PubMed  CAS  Google Scholar 

  • Takahashi T, Kuniyasu Y et al (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10:1969–1980

    Article  PubMed  CAS  Google Scholar 

  • Tan P, Anasetti C et al (1993) Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 177:165–173

    Article  PubMed  CAS  Google Scholar 

  • Taylor PA, Friedman TM et al (2002a) Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood 99:4601–4609

    PubMed  CAS  Google Scholar 

  • Taylor PA, Lees CJ et al (2002b) The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99:3493–3499

    PubMed  CAS  Google Scholar 

  • Taylor PA, Lees CJ et al (2003) Endogenous host or exogenous donor CD4+CD25+ cells promote donor BM engraftment: association with TGF-beta production regulation of GITR signaling (abstract). Blood 102:37a

    Google Scholar 

  • Taylor PA, Noelle RJ et al (2001) CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp 193:1311–1318

    CAS  Google Scholar 

  • Terabe M, Berzofsky JA (2004) Immunoregulatory T cells in tumor immunity. Opin Immunol 16:157–162

    CAS  Google Scholar 

  • Teshima T, Ordemann R et al (2002) Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med 8:575–581

    Article  PubMed  CAS  Google Scholar 

  • Thornton AM, Shevach EM (2000) Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 164:183–190

    PubMed  CAS  Google Scholar 

  • Trenado A, Charlotte F et al (2003) Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 112:1688–1696

    Article  PubMed  CAS  Google Scholar 

  • Truitt RL, Johnson BD (1995) Principles of graft-vs.-leukemia reactivity. Biol Blood Marrow Transplant 1:61–68

    PubMed  CAS  Google Scholar 

  • Vogelsang GB, Lee L et al (2003) Pathogenesis and treatment of graft-versus-disease after bone marrow transplant. Annu Rev Med 54:29–52

    Article  PubMed  CAS  Google Scholar 

  • Waldmann H, Graca L et al (2004) Regulatory T cells and organ transplantation. Semin Immunol 16:119–126

    Article  PubMed  CAS  Google Scholar 

  • Walker LS, Chodos A et al (2003) Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 198:249–258

    Article  PubMed  CAS  Google Scholar 

  • Wang XN, Proctor SJ et al (1996) Frequency analysis of recipient-reactive helper cytotoxic T lymphocyte precursors using a combined single limiting dilution assay. Transpl Immunol 4:247–251

    PubMed  CAS  Google Scholar 

  • Yamazaki S, Iyoda T et al (2003) Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198:235–247

    Article  PubMed  CAS  Google Scholar 

  • Zeng D, Lan F et al (2004) Suppression of graft-versus-host disease by naturally occurring regulatory T cells. Transplantation 77:S9–S11

    PubMed  Google Scholar 

  • Zeng D, Lewis D et al (1999) Bone marrow NK1.1(−) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 189:1073–1081

    Article  PubMed  CAS  Google Scholar 

  • Zhang ZX, Yang L et al (2000) Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 6:782–789

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Immunology, University Regensburg, Regensburg, Germany

    P. Hoffmann

  2. Department of Medicine, University of Tennessee, Memphis, Tennessee, USA

    J. Ermann

  3. Department of Hematology and Oncology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany

    M. Edinger

Authors
  1. P. Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Ermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Edinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Atlanta, Georgia

    R.W. Compans

  2. Birmingham, Alabama

    M.D. Cooper

  3. Kyoto

    T. Honjo

  4. Philadelphia, Pennsylvania

    H. Koprowski

  5. Basel

    F. Melchers

  6. La Jolla, California

    M.B.A. Oldstone  & P.K. Vogt  & 

  7. Oslo

    S. Olsnes

  8. Bethesda, Maryland

    M. Potter

  9. Munich

    H. Wagner

  10. Abteilung Entwicklungsimmunologie, Deutsches Krebsforschungszentrum Forschungsschwerpunkt Tumorimmunologie, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany

    Bruno Kyewski

  11. Abteilung Immungenetik, Deutsches Krebsforschungszentrum Forschungsschwerpunkt Tumorimmunologie, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany

    Elisabeth Suri-Payer

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hoffmann, P., Ermann, J., Edinger, M. (2005). CD4+CD25+ Regulatory T Cells in Hematopoietic Stem Cell Transplantation. In: Compans, R., et al. CD4+CD25+ Regulatory T Cells: Origin, Function and Therapeutic Potential. Current Topics in Microbiology and Immunology, vol 293. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27702-1_12

Download citation

Publish with us

Policies and ethics

Search

Navigation